Abbott has formally announced that two new sensors, the Freestyle Libre 2 Plus and Freestyle Libre 3 Plus for glucose monitoring in the management of diabetes are now available for people living with diabetes in Ireland.
The FreeStyle Libre 2 Plus sensor is reimbursed by the HSE for people living with Type 1 diabetes from age two upwards. The FreeStyle Libre 2 Plus sensor can be worn for up to 15 days, one day longer than previous iterations and demonstrates improved 15-day accuracy. As it replaces the FreeStyle Libre 2 sensor, it is recommended that people living with diabetes who currently use the FreeStyle Libre 2 sensor speak to their diabetes healthcare professional team to update their prescription to the new FreeStyle Libre 2 Plus sensor.
Abbott has also partnered with CamDiab and Ypsomed and the FreeStyle Libre 3 Plus sensor now works with a hybrid closed loop system – mylife CamAPS FX app and the mylife YpsoPump. The FreeStyle Libre 3 Plus sensor is available for people living with diabetes who are eligible for a hybrid closed loop system with the mylife Loop.
Diabetes Ireland’s Dr Kate Gajewska said “It’s exciting to see technology devices developing further and offering more choice, become available in Ireland under the HSE reimbursement scheme for people with Type 1 diabetes meeting eligibility criteria. Hopefully, we will see eligibility criteria expanded, and access to these and other technologies made more widely available to all people with diabetes in the future”.